Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C26H22BrN5O2 |
| Molecular Weight | 516.389 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NC2=C(C=C(CN(CC#C)C3=CC=C(C=C3)C(=O)NCC4=CC=CN=C4)C(Br)=C2)C(=O)N1
InChI
InChIKey=SHNBLWMBWXIKMR-UHFFFAOYSA-N
InChI=1S/C26H22BrN5O2/c1-3-11-32(16-20-12-22-24(13-23(20)27)30-17(2)31-26(22)34)21-8-6-19(7-9-21)25(33)29-15-18-5-4-10-28-14-18/h1,4-10,12-14H,11,15-16H2,2H3,(H,29,33)(H,30,31,34)
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue of the antifolate thymidylate synthase inhibitor ICI 198583 with an undefined mechanism of action. | 1998 Sep 1 |
|
| Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound. | 2010 Jun 25 |
Patents
Sample Use Guides
Growth inhibitory potency was determined after continuous exposure of cells to CB30865 for 48 h (L1210), 72 h (W1L2), or 96 h (CH1) followed by Coulter Counting (L1210 and W1L2) or 3-[4,5-dimethylthiazol-2yl]-2,5-diphenyltetrazolium bromide (MTT) assay. CB30865 inhibited tumor growth with IC50 values in the 1-10 nM range.
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70432117
Created by
admin on Sat Dec 16 20:09:58 GMT 2023 , Edited by admin on Sat Dec 16 20:09:58 GMT 2023
|
PRIMARY | |||
|
135528987
Created by
admin on Sat Dec 16 20:09:58 GMT 2023 , Edited by admin on Sat Dec 16 20:09:58 GMT 2023
|
PRIMARY | |||
|
206275-15-2
Created by
admin on Sat Dec 16 20:09:58 GMT 2023 , Edited by admin on Sat Dec 16 20:09:58 GMT 2023
|
PRIMARY | |||
|
QH8386GD3S
Created by
admin on Sat Dec 16 20:09:58 GMT 2023 , Edited by admin on Sat Dec 16 20:09:58 GMT 2023
|
PRIMARY |
![Structure of 4-[[(7-Bromo-3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]-2-propyn-1-ylamino]-N-(3-pyridinylmethyl)benzamide](/img/66fb352e-bb40-4619-90c9-fa529b007c58.svg "Structure of 4-[[(7-Bromo-3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]-2-propyn-1-ylamino]-N-(3-pyridinylmethyl)benzamide")